Suppr超能文献

血清全转钴胺素II水平降低。维生素B12负平衡的早期迹象。

Depletion of serum holotranscobalamin II. An early sign of negative vitamin B12 balance.

作者信息

Herzlich B, Herbert V

机构信息

Hematology and Nutrition Laboratory, Bronx VA Medical Center, Brooklyn, New York.

出版信息

Lab Invest. 1988 Mar;58(3):332-7.

PMID:3347009
Abstract

Preferential depletion of corrinoids on transcobalamin II (i.e., sharply reduced holo transcobalamin II (TC II)) occurs early in vitamin B12 deficiency. We measured corrinoids (Cor) and cobalamins (Cbl) on transcobalamins I and III (TC I + III) and on TC II. We also measured the unsaturated B12 binding capacities of transcobalamin I and III and TC II in serum from patients with B12 deficiency (N = 5) (with or without concurrent folate deficiency), with pernicious anemia in remission (N = 7) (1 month after therapy), and in several control groups including healthy volunteers (N = 6), hematologically normal elderly hospitalized patients (N = 5), and non-B12 nonfolate deficient anemic elderly hospitalized volunteers (N = 5). In B12 deficient patients, Cor = 177 +/- 92 pg/ml, Cbl = 56 +/- 20 pg/ml, TC II Cor = 1.0 +/- 2.2 pg/ml, and TC II Cbl = 4.4 +/- 4.9 pg/ml in contrast to pooled controls with Cor = 730 +/- 229, Cbl = 523 +/- 198, TC II Cor = 100 +/- 84, and TC II Cbl = 88 +/- 70 (all values expressed in picograms/milliliters). In pernicious anemia in remission, Cor = 505 +/- 138, Cbl = 294 +/- 77, TC II Cor = 80 +/- 31 and TC II Cbl = 37 +/- 36. TC II unsaturated B12 binding capacity was significantly higher in B12 deficient patients than in pooled controls. These data support that: (a) holo TC II is sharply depleted in untreated B12 deficiency; (b) normally, the only Cor on TC II are cobalamins; (c) in treated pernicious anemia, TC II appears to also bind non-cobalamin corrinoids; (d) continued malabsorption of vitamin B12 may result in reduced B12 on TC II within a month after the last parenteral therapy with 1000 micrograms of cyanocobalamin, and (e) TC II UBBC rises as B12 deficiency is developing. Further investigation is required for definitive delineation of whether sharply reduced Cor on TC II in untreated B12 deficiency can diagnose "true" B12 deficiency, in view of false positive or false negative results which occur in all serum B12 assays.

摘要

在维生素B12缺乏早期,钴胺素在转钴胺素II上优先耗竭(即全转钴胺素II(TC II)急剧减少)。我们测定了转钴胺素I和III(TC I + III)以及TC II上的钴胺素(Cor)和钴胺类维生素(Cbl)。我们还测定了维生素B12缺乏患者(N = 5)(伴有或不伴有同时存在的叶酸缺乏)、处于缓解期的恶性贫血患者(N = 7)(治疗后1个月)以及包括健康志愿者(N = 6)、血液学正常的老年住院患者(N = 5)和非维生素B12非叶酸缺乏的贫血老年住院志愿者(N = 5)在内的几个对照组血清中转钴胺素I和III以及TC II的不饱和B12结合能力。在维生素B12缺乏患者中,Cor = 177 +/- 92 pg/ml,Cbl = 56 +/- 20 pg/ml,TC II Cor = 1.0 +/- 2.2 pg/ml,TC II Cbl = 4.4 +/- 4.9 pg/ml,而合并对照组的Cor = 730 +/- 229,Cbl = 523 +/- 198,TC II Cor = 100 +/- 84,TC II Cbl = 88 +/- 70(所有值均以皮克/毫升表示)。在处于缓解期的恶性贫血患者中,Cor = 505 +/- 138,Cbl = 294 +/- 77,TC II Cor = 80 +/- 31,TC II Cbl = 37 +/- 36。维生素B12缺乏患者的TC II不饱和B12结合能力显著高于合并对照组。这些数据支持:(a)在未经治疗的维生素B12缺乏中,全TC II急剧减少;(b)正常情况下,TC II上唯一的Cor是钴胺类维生素;(c)在治疗后的恶性贫血中,TC II似乎也结合非钴胺素的钴胺素;(d)持续的维生素B12吸收不良可能导致在最后一次注射1毫克氰钴胺治疗后一个月内TC II上的B12减少;(e)随着维生素B12缺乏的发展,TC II UBBC升高。鉴于所有血清B12检测中都会出现假阳性或假阴性结果,对于未经治疗的维生素B12缺乏中TC II上Cor急剧减少是否可诊断“真正的”维生素B12缺乏,还需要进一步研究以明确界定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验